www.aaclaimsupport.comAACS provides you with services that enable your basic research in the field of dermatology with a focus on skin care science, testing of dermatological ingredients and procedures, photobiology and skin stress- and aging

MedTech, www.simcharacters.comSIMCharacters - High Emotion Simulation represents a concept based on premature infant- simulators which is unique worldwide. These convincingly realistic simulators allow childhood pathologies to be simulated and simulation-based training which delivers previously unattained training outputs.

http://www.wtz-ost.at

www.zytoprotec.comZytoprotec is developing drugs using a novel therapeutic approach – cytoprotection.Zytoprotec’s lead product, PD-protec®, is being developed to improve the survival of patients on peritoneal dialysis, a treatment for kidney failure.A randomized, blinded, multicenter Phase II trial has commenced at the end of Q2 2014.

Holdinggesellschaft für kommerzielle Spin Off Gründungen der Medizinischen Universität Wien.Mission StatementDie Mission der MUW-FSB ist die erfolgreiche Kommerzialisierung von Innovationen der Medizinischen Universität Wien und damit die Erzielung einer nachhaltigen Wertschöpfung. Die MUW-FSB versteht sich als Partner innovativer WissenschaftlerInnen der MedUni Wien, als Schnittstelle zur Wirtschaft sowie als Inkubator für Firmengründungen. Der Bereich Technologietransfer der MUW ist Meldestelle für Diensterfindungen und zuständig für das Patent- & Lizenzmanagement der MedUni Wien. Die MUW-FSB unterstützt darüber hinaus potentielle Gründer der MedUni Wien und schafft die notwendigen attraktiven und transparenten Rahmenbedingungen für Firmengründungen.

GAT Food Essentials (GAT) is a recognized microencapsulation specialist focusing on the stabilization of sensitive active ingredients - such as PUFAs (omega-3), nutritional oils, antioxidants, minerals, and vitamins – for the functional food and beverage industry. Our strength lies in providing a natural, easy-to-use, and stable technology solution (wowCAPS® technology) for the incorporation of a variety of active ingredients into food and beverage applications.The addition of GAT’s microencapsulated functional food ingredients requires minimal New Product Development efforts from our customers or changes to already optimized production processes, thus providing a simple way of adding value to and differentiating foods and beverages through the combination of nutritional ingredients with innovative technology.

GAT Microencapsulation GmbH ("GAT", "the Company") is an agrochemical company specializing in the development, registration and manufacture of advanced plant protection products. These products are based on GAT's proprietary formulation technologies.GAT Formulation GmbH was founded in 1999 by a group of highly specialized scientists to provide R&D and analytical services to the industry. After a few years of encouraging growth GAT established state of the art laboratories (GLP) and manufacturing facilities. In 2004, GAT Microencapsulation GmbH started industrial manufacturing of high quality agrochemical products.GAT has developed innovative and cost-effective technologies for the formulation of agrochemicals, most notably microencapsulation. The company's intellectual property in these technologies is based upon a complex combination of 9 international patents.GAT is currently engaged in the registration and marketing technologically advanced generic agrochemical products (agro-generics) and biocidal products in the EU, USA, South America, Asia and Africa. GAT is bringing to these markets proprietary products based on its own technologies.

div. Interimsmanagemtnposition, Beratungen CFO, Branche vorwiegend Pharmazeutika

SANOCHEMIA Pharmazeutika AG is a specialty pharmaceuticals company with its own production facilities and outstanding levels of developmental expertise.We are firmly established in the indication areas of neurodegeneration, pain, oncology and clinical diagnostics – all of which are characterised by high therapeutic demands and urgent need for innovative drugs to improve patient quality of life.